For lung adenocarcinoma with just EGFR L858R mutation, the Observation group had a better ORR, mPFS, and 2-year survival than the EGFR-TKIs alone group, but DCR and 1-year survival were not significantly different (Tables 7 and 8; Fig. 3). Here, EGFR is linked to lung adenocarcinoma.